Skip to main content
. 2017 Dec 6;23(3):360–366. doi: 10.1634/theoncologist.2017-0408

Figure 1.

image

Consolidated Standards of Reporting Trials diagram of the retrospective study of DSRCT patients receiving pazopanib.

Abbreviations: DSRCT, desmoplastic small round cell tumor; HDAC, histone deacetylase; mTOR, mammalian target of rapamycin; RECIST, Response Evaluation Criteria In Solid Tumors.